Use and perception of telemedicine in people with type 1 diabetes during the COVID-19 pandemic Results of a global survey

被引:46
|
作者
Scott, Sam N. [1 ,2 ]
Fontana, Federico Y. [2 ]
Zueger, Thomas [1 ,3 ]
Laimer, Markus [1 ]
Stettler, Christoph [1 ]
机构
[1] Univ Bern, Bern Univ Hosp, Dept Diabet Endocrinol Nutr Med & Metab, Bern, Switzerland
[2] Team Novo Nordisk Profess Cycling Team, Atlanta, GA USA
[3] Swiss Fed Inst Technol, Dept Management Technol & Econ, Zurich, Switzerland
关键词
COVID-19; telemedicine; type; 1; diabetes;
D O I
10.1002/edm2.180
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The COVID-19 pandemic has forced rapid reconsideration as to the way in which health care is delivered. One potential means to provide care while avoiding unnecessary person-to-person contact is to offer remote services (telemedicine). This study aimed to (1) gather real-time information on the use and perception of telemedicine in people living with type 1 diabetes and (2) assess the challenges, such as restricted access to health care and/or medical supplies. Methods: An anonymous questionnaire was widely distributed between 24 March and 5 May 2020 using an open-access web-based platform. Data were analysed descriptively, and results were stratified according to age, sex and HbA(1c). Results: There were 7477 survey responses from individuals in 89 countries. Globally, 30% reported that the pandemic had affected their healthcare access due to cancelled physical appointments with their healthcare providers. Thirty-two per cent reported no fundamental change in their medical follow-up during this period, with 9% stating that no personal contact was established with their doctors over the duration of the study. Twenty-eight per cent received remote care through telephone (72%) or video-calls (28%). Of these, 86% found remote appointments useful and 75% plan to have remote appointments in the future. Glucose control, indicated by HbA(1c), was positively associated with positive perception of telemedicine. In males, 45% of respondents with an HbA(1c) > 9% rated telemedicine not useful compared to those with lower HbA(1c), while 20% of females with an HbA(1c) > 9% rated it not useful (chi(2) = 14.2, P = .0016). Conclusion: Remote appointments have largely been perceived as positive in people with type 1 diabetes with the majority (75%) stating that they would consider remote appointments beyond the pandemic. Age and level of education do not appear to influence perception of telemedicine, whereas poor glucose control, particularly in males, seems to negatively affect perception.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Lights and Shadows of the Perception of the Use of Telemedicine by Romanian Family Doctors During the COVID-19 Pandemic
    Florea, Mira
    Lazea, Cecilia
    Gaga, Remus
    Sur, Genel
    Lotrean, Lucia
    Puia, Aida
    Stanescu, Ana Maria Alexandra
    Lupsor-Platon, Monica
    Florea, Horatiu
    Sur, Maria Lucia
    [J]. INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 1575 - 1587
  • [22] Telemedicine Use by Oculoplastic Surgeons During the COVID-19 Pandemic
    Lelli, Gary J.
    Luo, Susan
    Liu, Yao
    van Landingham, Suzanne W.
    [J]. TELEMEDICINE AND E-HEALTH, 2022, 28 (06) : 878 - 887
  • [23] Telemedicine use by pediatric rheumatologists during the COVID-19 pandemic
    Rajdeep Pooni
    Tova Ronis
    Tzielan Lee
    [J]. Pediatric Rheumatology, 19
  • [24] Improved glucometrics in people with type 1 diabetes 1 year into the COVID-19 pandemicImproved glucometrics in people with type 1 diabetes 1 year into the COVID-19 pandemic
    Ali, Namam
    El Hamdaoui, Soumia
    Nefs, Giesje
    Tack, Cornelis J.
    De Galan, Bastiaan E.
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2022, 10 (03)
  • [25] Telemedicine use by pediatric rheumatologists during the COVID-19 pandemic
    Pooni, Rajdeep
    Ronis, Tova
    Lee, Tzielan
    [J]. PEDIATRIC RHEUMATOLOGY, 2021, 19 (01)
  • [26] Telemedicine use in orthopaedics: Experience during the COVID-19 pandemic
    Chin, Brian Z.
    Nashi, Nazrul
    Lin, Shuxun
    Yik, Kevin
    Tan, Gamaliel
    Kagda, Fareed Hy
    [J]. JOURNAL OF TELEMEDICINE AND TELECARE, 2022, 28 (05) : 373 - 379
  • [27] Telemedicine for type 2 diabetes during COVID-19 pandemic: experience from a tertiary diabetes center
    Angelino, Silvia
    Caruso, Paola
    Longo, Miriam
    Barrasso, Mariluce
    Castaldo, Filomena
    Pontillo, Alessandro
    Arena, Stefania
    Palmieri, Annarita
    Bellastella, Giuseppe
    Maiorino, Maria I.
    Esposito, Katherine
    [J]. MINERVA ENDOCRINOLOGY, 2024,
  • [28] COVID-19 pandemic lockdown in young people with type 1 diabetes: Positive results of an unprecedented challenge for patients through telemedicine and change in use of continuous glucose monitoring
    Salabelle, Claire
    Sall, Khadijatou Ly
    Eroukhmanoff, Juliette
    Franc, Sylvia
    Oumbiche, Hamida
    Zrafi, Wael Salem
    Thanh Lan Dang Duy
    Valentim, Clarisse
    Gaston, Floriane
    Fernandes, Sylvie
    Faucherand, Marie
    Penfornis, Alfred
    Amadou, Coralie
    [J]. PRIMARY CARE DIABETES, 2021, 15 (05) : 884 - 886
  • [29] Worry Perception of the COVID-19 Pandemic in Children and Adolescents with Type 1 Diabetes
    Salah, Nouran Y.
    Abido, Amal Y.
    Rashed, Hebatallah R.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 116 : 45 - 45
  • [30] The effect of the COVID-19 pandemic on telemedicine in pediatric diabetes centers in Italy: Results from a longitudinal survey
    Tornese, Gianluca
    Schiaffini, Riccardo
    Mozzillo, Enza
    Franceschi, Roberto
    Frongia, Anna Paola
    Scaramuzza, Andrea
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 179